東華大學圖書館 |

Breaking Down the Barriers : The Effects of Aging, Gut Microbiota and Bile Acids on Intestinal Health.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Breaking Down the Barriers : The Effects of Aging, Gut Microbiota and Bile Acids on Intestinal Health./
作者:	Lugt, Benthe van der.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2021,
面頁冊數:	276 p.
附註:	Source: Dissertations Abstracts International, Volume: 83-07, Section: B.
Contained By:	Dissertations Abstracts International83-07B.
標題:	Infections. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28854499
ISBN:	9798759927358

Breaking Down the Barriers : The Effects of Aging, Gut Microbiota and Bile Acids on Intestinal Health.
Lugt, Benthe van der.

Breaking Down the Barriers : The Effects of Aging, Gut Microbiota and Bile Acids on Intestinal Health. - Ann Arbor : ProQuest Dissertations & Theses, 2021 - 276 p.

Source: Dissertations Abstracts International, Volume: 83-07, Section: B.

Thesis (Ph.D.)--Wageningen University and Research, 2021.

This item must not be sold to any third party vendors.

It is widely acknowledged that the intestine plays an essential role in the maintenance of overall health. The intestinal barrier is responsible to carry out this highly important, but complex task. The intestinal barrier include the mucus layer, the intestinal epithelial cell layer and the immune cell 'layer'. In a healthy condition, the trillions of micro-organisms that are present in the intestinal tract have a beneficial relationship with the host. However, in case these highly regulated processes are impaired, the risk of (intestinal) diseases increases. As the prevalence of intestinal disorders is increasing worldwide, there is a high urgency to increase the scientific knowledge in the field of intestinal health. The aim of this thesis was to investigate the effects of relevant aspects that are known to be involved in intestinal health: the aging process, gut microbiota, and bile acids. To investigate this, we used relevant in vivo and in vitro modelsThe life-expectancy of humans has increased over the past centuries. However, the aging process increases the risk of disease, including intestinal disorders. To improve healthy aging, it is important to gain insight in the mechanisms underlying aging-related impaired intestinal health. In Chapter 2, we investigated the effects of the aging process on different aspects of intestinal health using C57BL/6J mice aged 6, 12, 24 and 28 months. We found pronounced changes in gut microbiota composition during aging, including an enrichment of potential pathobionts and a decline in healthpromoting bacteria, such as Akkermansia spp. Transcriptome analysis of colonic scrapings pointed towards a decreased intestinal immune response during aging. To explore interactions between the gut microbiota and host colonic gene expression, a comprehensive integrative analysis was performed. The observed correlations between specific bacterial genera and host gene expression may serve as a starting point for future studies investigating the exact host-microbe interactions that take place in the vicinity of the colonic wall.Since a detrimental shift in gut microbiota composition is frequently observed during aging, manipulation of the gut microbiota in the aged population could be a strategy to enhance healthy aging. A highly promising candidate is Akkermansia muciniphila, since a wide range of studies showed that this bacterium has beneficial effects on low-grade inflammation and (cardio)metabolic disorders. However, the effects of A. muciniphila on intestinal health parameters are not widely investigated yet. In Chapter 3, we supplemented progeroid Ercc1Δ-/7 mice with A. muciniphila for 10 weeks and investigated histological, transcriptional and immunological aspects of intestinal health. We found that the thickness of the colonic mucus layer increased about 3-fold in supplemented mice compared to the control group that did not receive supplementation. Moreover, both transcriptomic and immunological analysis revealed an improved immune status. These results highlight the potential anti-inflammatory properties of A. muciniphila, which serve as a starting point for future studies investigating the use of this bacterium as a therapeutic intervention in the elderly population.The involvement of the gut microbiota in inflammatory disorders of the intestine, such as IBD, is widely acknowledged. Bacterial metabolites, which are the end products of bacterial metabolism, have a great influence on intestinal health, such as immune response and intestinal barrier function. Therefore, the shift in bacterial metabolite composition as a result of IBD-related dysbiosis could play a role in IBD pathology. In a previous study, increased levels of sulfated BAs were found in IBD patients, but the exact effect of sulfated BAs on disease progression has not been investigated yet.

ISBN: 9798759927358Subjects--Topical Terms:

1621997
Infections.

Breaking Down the Barriers : The Effects of Aging, Gut Microbiota and Bile Acids on Intestinal Health.
LDR:05063nmm a2200385 4500 001 2347548
005 20220801062235.5
008 241004s2021 ||||||||||||||||| ||eng d
020 $a 9798759927358
035 $a (MiAaPQ)AAI28854499
035 $a (MiAaPQ)Wageningen586967
035 $a AAI28854499
040 $a MiAaPQ $c MiAaPQ
100 1 $a Lugt, Benthe van der. $3 3686816
245 1 0 $a Breaking Down the Barriers : The Effects of Aging, Gut Microbiota and Bile Acids on Intestinal Health.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2021
300 $a 276 p.
500 $a Source: Dissertations Abstracts International, Volume: 83-07, Section: B.
500 $a Advisor: Kersten, A. H. ;Steegenga, W. T. .
502 $a Thesis (Ph.D.)--Wageningen University and Research, 2021.
506 $a This item must not be sold to any third party vendors.
520 $a It is widely acknowledged that the intestine plays an essential role in the maintenance of overall health. The intestinal barrier is responsible to carry out this highly important, but complex task. The intestinal barrier include the mucus layer, the intestinal epithelial cell layer and the immune cell 'layer'. In a healthy condition, the trillions of micro-organisms that are present in the intestinal tract have a beneficial relationship with the host. However, in case these highly regulated processes are impaired, the risk of (intestinal) diseases increases. As the prevalence of intestinal disorders is increasing worldwide, there is a high urgency to increase the scientific knowledge in the field of intestinal health. The aim of this thesis was to investigate the effects of relevant aspects that are known to be involved in intestinal health: the aging process, gut microbiota, and bile acids. To investigate this, we used relevant in vivo and in vitro modelsThe life-expectancy of humans has increased over the past centuries. However, the aging process increases the risk of disease, including intestinal disorders. To improve healthy aging, it is important to gain insight in the mechanisms underlying aging-related impaired intestinal health. In Chapter 2, we investigated the effects of the aging process on different aspects of intestinal health using C57BL/6J mice aged 6, 12, 24 and 28 months. We found pronounced changes in gut microbiota composition during aging, including an enrichment of potential pathobionts and a decline in healthpromoting bacteria, such as Akkermansia spp. Transcriptome analysis of colonic scrapings pointed towards a decreased intestinal immune response during aging. To explore interactions between the gut microbiota and host colonic gene expression, a comprehensive integrative analysis was performed. The observed correlations between specific bacterial genera and host gene expression may serve as a starting point for future studies investigating the exact host-microbe interactions that take place in the vicinity of the colonic wall.Since a detrimental shift in gut microbiota composition is frequently observed during aging, manipulation of the gut microbiota in the aged population could be a strategy to enhance healthy aging. A highly promising candidate is Akkermansia muciniphila, since a wide range of studies showed that this bacterium has beneficial effects on low-grade inflammation and (cardio)metabolic disorders. However, the effects of A. muciniphila on intestinal health parameters are not widely investigated yet. In Chapter 3, we supplemented progeroid Ercc1Δ-/7 mice with A. muciniphila for 10 weeks and investigated histological, transcriptional and immunological aspects of intestinal health. We found that the thickness of the colonic mucus layer increased about 3-fold in supplemented mice compared to the control group that did not receive supplementation. Moreover, both transcriptomic and immunological analysis revealed an improved immune status. These results highlight the potential anti-inflammatory properties of A. muciniphila, which serve as a starting point for future studies investigating the use of this bacterium as a therapeutic intervention in the elderly population.The involvement of the gut microbiota in inflammatory disorders of the intestine, such as IBD, is widely acknowledged. Bacterial metabolites, which are the end products of bacterial metabolism, have a great influence on intestinal health, such as immune response and intestinal barrier function. Therefore, the shift in bacterial metabolite composition as a result of IBD-related dysbiosis could play a role in IBD pathology. In a previous study, increased levels of sulfated BAs were found in IBD patients, but the exact effect of sulfated BAs on disease progression has not been investigated yet.
590 $a School code: 2157.
650 4 $a Infections. $3 1621997
650 4 $a Physiology. $3 518431
650 4 $a Glycoproteins. $3 667972
650 4 $a Pathogens. $3 3540520
650 4 $a Food. $3 551593
650 4 $a Bacteria. $3 550366
650 4 $a Fatty acids. $3 897910
650 4 $a Amino acids. $3 558768
650 4 $a Peptides. $3 605772
650 4 $a Apoptosis. $3 600650
650 4 $a Kinases. $3 3558077
650 4 $a Electrolytes. $3 656992
650 4 $a Parasites. $3 671720
650 4 $a Colon. $3 3560379
650 4 $a Immune system. $3 689864
650 4 $a Defense mechanisms. $3 3684931
650 4 $a Antimicrobial agents. $3 3556833
650 4 $a Chemical bonds. $3 560512
650 4 $a Immunoglobulins. $3 898739
650 4 $a Antigens. $3 700737
650 4 $a Phosphorylation. $3 816803
650 4 $a Cell growth. $3 3560747
650 4 $a Enzymes. $3 520899
650 4 $a Metabolites. $3 683644
650 4 $a Atomic physics. $3 3173870
650 4 $a Biology. $3 522710
650 4 $a Cellular biology. $3 3172791
650 4 $a Immunology. $3 611031
650 4 $a Medicine. $3 641104
650 4 $a Parasitology. $3 635062
650 4 $a Physics. $3 516296
690 $a 0719
690 $a 0748
690 $a 0306
690 $a 0379
690 $a 0982
690 $a 0564
690 $a 0718
690 $a 0605
710 2 $a Wageningen University and Research. $3 3557914
773 0 $t Dissertations Abstracts International $g 83-07B.
790 $a 2157
791 $a Ph.D.
792 $a 2021
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28854499